Status:
COMPLETED
Effect of NT-proBNP Guided Treatment of Chronic Heart Failure
Lead Sponsor:
Netherlands Heart Foundation
Collaborating Sponsors:
The Interuniversity Cardiology Institute of the Netherlands
Conditions:
Heart Failure, Congestive
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to determine whether NT-proBNP guided treatment of chronic congestive heart failure will reduce heart failure related morbidity and mortality compared to therapy guided by...
Eligibility Criteria
Inclusion
- Admission because of congestive heart failure
- Elevated NT-proBNP levels on admission
Exclusion
- Life-threatening cardiac arrhythmias
- Urgent intervention
- Severe lung disease
- Presence of life threatening disease
- Signed informed consent for other study
- Mental or physical status not allowing written informed consent.
- Unwillingness to give informed consent
- Patients undergoing haemodialysis or continuous ambulatory peritoneal dialysis (CAPD)
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
End Date :
April 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00149422
Start Date
June 1 2004
End Date
April 1 2009
Last Update
February 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universtiy Hospital Maastricht
Maastricht, Limburg, Netherlands, 5800